Microcap Ledger AEON Biopharma, Inc. $AEON
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- NYSE American
- Sector
- Pharmaceutical Preparations
- Headquarters
- Aliso Viejo, CA
- Fiscal year end
- December 31
- Shares outstanding
- 49,882,790 [10-Q 2026-08-12]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$12.95M | −$6.33M | $3.43M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | — | −$39.22M | −$17.31M | $3.01M | [10-K 2026-03-30] |
| FY ended Dec 2024 | — | $42.01M | −$20.29M | $13.0K | [10-K 2026-03-30] |
- Quarterly cash burn
- −$3.17M
- Cash runway Estimate
- ~3.3 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-11 | 39,970,693 | [10-Q 2024-11-13] |
| 2025-03-21 | 10,532,802 | [10-K/A 2025-06-11] |
| 2025-05-07 | 11,305,367 | [10-Q/A 2025-06-11] |
| 2025-08-08 | 1,164,378 | [10-Q 2025-08-12] |
| 2025-11-10 | 11,838,447 | [10-Q 2025-11-14] |
| 2026-03-23 | 25,303,058 | [10-K 2026-03-30] |
| 2026-05-11 | 26,307,211 | [10-Q 2026-05-14] |
| 2026-08-06 | 49,882,790 | [10-Q 2026-08-12] |
- Shelf registration
- S-1 filed 2026-07-08; declared effective 2026-07-13 [S-1 2026-07-08]
Listing status
Current status: 3 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-03. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-04-03 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-04-03] |
| 2025-04-25 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-04-25] |
| 2025-02-07 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-02-07] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-19 | Lynch Timothy P | buy | 1,150,000 | $0.21 | [4 2026-08-21] |
| 2026-06-17 | Thunen Shelley B | grant | 222,684 | — | [4 2026-06-22] |
| 2026-06-17 | Palmisano Robert J | grant | 222,684 | — | [4 2026-06-22] |
| 2026-06-17 | Forth Marc | grant | 222,684 | — | [4 2026-06-22] |
| 2026-06-17 | Fischer Jost | grant | 222,684 | — | [4 2026-06-22] |
| 2026-06-17 | Carter Eric G | grant | 222,684 | — | [4 2026-06-22] |
| 2026-04-02 | Bencich John | grant | 754,717 | — | [4 2026-04-03] |
| 2026-03-04 | Oh Chad | grant | 1,316,872 | — | [4 2026-03-11] |
| 2026-02-17 | Oh Chad | grant | 862,500 | — | [4 2026-03-11] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-30 | 8-K | Regulation FD disclosure; Other events |
| 2026-08-21 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-08-12 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-08-03 | 8-K | Regulation FD disclosure; Other events |
| 2026-07-23 | 8-K | Other events |
| 2026-07-21 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-07-15 | 8-K | Material agreement entered; Other events |
| 2026-07-15 | 424B4 | Prospectus or prospectus supplement |
| 2026-07-09 | S-1/A | Registration statement |
| 2026-07-08 | S-1 | Registration statement |
| 2026-06-17 | 8-K | Shareholder vote results |
Alerts for $AEON
Email me when AEON Biopharma, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.